Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance. (Q50906941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Marina Makrecka-Kuka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Elina Makarova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kristine Volska

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Baiba Svalbe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Eduards Sevostjanovs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Solveiga Grinberga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Janis Kuka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Maija Dambrova

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

24 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

published in

Pharmacological Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

788-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

Pt B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

1 March 2020

cites work

1 reference

12 August 2022

https://opencitations.net/index/coci/api/v1/citations/10.1042/BJ20082159

Identifiers

DOI

10.1016/J.PHRS.2015.11.014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26621248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference